Chen Kang Pharmaceutical Group is mainly engaged in the production and operation of chemical synthesis, raw materials, small-volume injections, granules, tablets, pills, oral liquid (pretreatment and extraction of traditional Chinese medicine), oral liquid and other dosage forms, and has established a perfect quality assurance system with advanced scientific and technological level. The Group's production base has successfully passed the national GMP certification. Guangdong Chen Kang Pharmaceutical Group has large industrial parks and several world-class pharmaceutical production lines in Guangzhou and Inner Mongolia, and its equipment and technical level are at the leading level in the industry. Chen Kang Pharmaceutical always pursues high-tech, high-efficiency and high-quality products, and has established "Chen Kang Nephrology Drug Research Center" with many authoritative medical research institutions at home and abroad, which has excellent product development capabilities. Among them, "Niaoduqing Granule (sugar-free type)", the leading product in the group's series of nephropathy products, is the first specialized drug approved by the Ministry of Health to treat chronic renal failure in the early and middle stages, which fills the gap in the treatment of chronic renal failure with traditional Chinese medicine preparations and has obtained national patents and national protected varieties of traditional Chinese medicine; Gadolinium gluconate injection (MRI contrast agent) fills the gap in the use of nuclear magnetic resonance imaging in China. It belongs to the national second-class new drug and is the first drug produced by Chen Kang Pharmaceutical. The above drugs have been listed in the national basic medical insurance drugs and rational drug use in the military.
Chen Kang Pharmaceutical Group has established a marketing system covering 3/kloc-0 provinces, municipalities and autonomous regions in China. While consolidating and developing the domestic market, Chen Kang pharmaceutical industry is constantly exploring the international market. At present, Chen Kang pharmaceutical products have been sold to Hong Kong, Macao, Taiwan, Southeast Asia, Japan, the United States, Canada and other countries and regions.